Cargando…
Acotiamide Has No Effects on Esophageal Motor Activity or Esophagogastric Junction Compliance
BACKGROUND/AIMS: The novel prokinetic drug acotiamide is used for treatment of functional dyspepsia. It is still unclear how acotiamide has effects on esophageal motor function. Esophageal peristalsis and esophagogastric junction (EGJ) compliance has an important role for prevention of esophageal mu...
Autores principales: | Mikami, Hironobu, Ishimura, Norihisa, Okada, Mayumi, Izumi, Daisuke, Okimoto, Eiko, Ishihara, Shunji, Kinoshita, Yoshikazu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Neurogastroenterology and Motility
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885723/ https://www.ncbi.nlm.nih.gov/pubmed/29605979 http://dx.doi.org/10.5056/jnm16111 |
Ejemplares similares
-
Effects of Metoclopramide on Esophageal Motor Activity and Esophagogastric Junction Compliance in Healthy Volunteers
por: Mikami, Hironobu, et al.
Publicado: (2016) -
Effects of acotiamide on esophageal motor function and gastroesophageal reflux in healthy volunteers
por: Ishimura, Norihisa, et al.
Publicado: (2015) -
Mucosal breaks show same circumferential distribution in majority of patients with recurrent reflux esophagitis
por: Fukuda, Naoki, et al.
Publicado: (2017) -
Ankylosaurus back sign: novel endoscopic finding in esophageal eosinophilia patients indicating proton pump inhibitor response
por: Ishimura, Norihisa, et al.
Publicado: (2018) -
Isolated Superior Mesenteric Artery Dissection with Small Intestine Ischemia
por: Aimi, Masahito, et al.
Publicado: (2015)